Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating Expenses:
Research and development	$ 36,268	$ 25,192
General and administrative	18,184	11,374
Total operating expenses	54,452	36,566
Other Income (Expense):
Interest and other income, net	5,325	2,861
Interest expense	(398)	(364)
Total other income, net	4,927	2,497
Net Loss	$ (49,525)	$ (34,069)
Net loss per share, basic	$ (0.59)	$ (0.50)
Net loss per share, diluted	$ (0.59)	$ (0.50)
Weighted average number of shares used in computing net loss per share, basic	83,905	68,403
Weighted average number of shares used in computing net loss per share, diluted	83,905	68,403
Comprehensive Loss:
Net loss	$ (49,525)	$ (34,069)
Other comprehensive income:
Unrealized gain on marketable securities	455	2,136
Comprehensive Loss	$ (49,070)	$ (31,933)